Erratum: Quebec platelet disorder: update on pathogenesis, diagnosis, and treatment (Seminars in Thrombosis and Hemostasis (2011) 37: 6 DOI: 10.1055/s-0031-1291382);Quebec platelet disorder: Update on pathogenesis, diagnosis, and treatment

Seminars in Thrombosis and Hemostasis

Volumn 37, Issue 6, 2011, Pages 713-719

  Blavignac, Jessica ^a   Bunimov, Natalia ^a   Rivard, Georges E ^b   Hayward, Catherine P M ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

congenital platelet disorders; congenital thrombocytopenia; fibrinolysis; platelets; Quebec platelet disorder; urokinase plasminogen activator

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; TRANEXAMIC ACID; UROKINASE;

ARTICLE; AUTOSOMAL DOMINANT DISORDER; BLEEDING DISORDER; BLOOD CLOT LYSIS; FIBRINOLYSIS; GENE MUTATION; HUMAN; MEGAKARYOCYTE; PATHOGENESIS; PRIORITY JOURNAL; QUEBEC PLATELET DISORDER; THROMBOCYTOPENIA;

EID: 81755172551     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0038-1625972     Document Type: Erratum

References (20)

1. Diamandis M, Veljkovic D K., Maurer-Spurej E, Rivard G E., Hayward C P. Quebec platelet disorder: features, pathogenesis and treatment. Blood Coagul Fibrinolysis 2008 19 2 109-119
2. Veljkovic D K., Rivard G E., Diamandis M, Blavignac J, Cramer-Bordé E M., Hayward C P. Increased expression of urokinase plasminogen activator in Quebec platelet disorder is linked to megakaryocyte differentiation. Blood 2009 113 7 1535-1542
3. Diamandis M, Paterson A D., Rommens J M. et al. Quebec platelet disorder is linked to the urokinase plasminogen activator gene (PLAU) and increases expression of the linked allele in megakaryocytes. Blood 2009 113 7 1543-1546
4. Kahr W H., Zheng S, Sheth P M. et al. Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activator. Blood 2001 98 2 257-265
5. Diamandis M, Adam F, Kahr W H. et al. Insights into abnormal hemostasis in the Quebec platelet disorder from analyses of clot lysis. J Thromb Haemost 2006 4 5 1086-1094
6. Diamandis M, Veljkovic D K., Derome F, Rivard G E., Hayward C P. Evaluation of urokinase plasminogen activator in urine from individuals with Quebec platelet disorder. Blood Coagul Fibrinolysis 2008 19 5 463-464
7. Paterson A D., Rommens J M., Bharaj B et al. Persons with Quebec platelet disorder have a tandem duplication of PLAU, the urokinase plasminogen activator gene. Blood 2010 115 6 1264-1266
8. Tracy P B., Giles A R., Mann K G., Eide L L., Hoogendoorn H, Rivard G E. Factor V (Quebec): a bleeding diathesis associated with a qualitative platelet Factor V deficiency. J Clin Invest 1984 74 4 1221-1228
9. Hayward C P., Rivard G E., Kane W H. et al. An autosomal dominant, qualitative platelet disorder associated with multimerin deficiency, abnormalities in platelet factor V, thrombospondin, von Willebrand factor, and fibrinogen and an epinephrine aggregation defect. Blood 1996 87 12 4967-4978
10. Hayward C P., Cramer E M., Kane W H. et al. Studies of a second family with the Quebec platelet disorder: evidence that the degradation of the alpha-granule membrane and its soluble contents are not secondary to a defect in targeting proteins to alpha-granules. Blood 1997 89 4 1243-1253
11. Janeway C M., Rivard G E., Tracy P B., Mann K G. Factor V Quebec revisited. Blood 1996 87 9 3571-3578
12. Hayward C P., Welch B, Bouchard M, Zheng S, Rivard G E. Fibrinogen degradation products in patients with the Quebec platelet disorder. Br J Haematol 1997 97 2 497-503
13. McKay H, Derome F, Haq M A. et al. Bleeding risks associated with inheritance of the Quebec platelet disorder. Blood 2004 104 1 159-165
14. Hayward C P., Rivard G E. Quebec platelet disorder. Expert Rev Hematol 2011 4 2 137-141
15. Homo Sapiens Chromosome 10. NCBI Map Viewer Website: Homo sapiens (human) genome view Build 36 6 statistics 2009. http://www.ncbi.nlm.nih.gov/projects/ mapview/maps.cgi?taxid=9606&chr=10 Accessed October 10, 2010
16. Abbasi A H., Shaikh Q, Hussain S A. Quebec platelet disorder. J Coll Physicians Surg Pak 2010 20 8 549-550
17. Sheth P M., Kahr W H., Haq M A., Veljkovic D K., Rivard G E., Hayward C P. Intracellular activation of the fibrinolytic cascade in the Quebec platelet disorder. Thromb Haemost 2003 90 2 293-298
18. Kufrin D, Eslin D E., Bdeir K et al. Antithrombotic thrombocytes: ectopic expression of urokinase-type plasminogen activator in platelets. Blood 2003 102 3 926-933
19. Heckel J L., Sandgren E P., Degen J L., Palmiter R D., Brinster R L. Neonatal bleeding in transgenic mice expressing urokinase-type plasminogen activator. Cell 1990 62 3 447-456
20. Weiss H J., Lages B, Zheng S, Hayward C P. Platelet factor V New York: a defect in factor V distinct from that in factor V Quebec resulting in impaired prothrombinase generation. Am J Hematol 2001 66 2 130-139